Buprenorphine And Naloxone Film
Product Images NDC 50742-365

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 50742-365). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ctn12mg.jpg (Ctn12mg)

Packaging label for Buprenorphine and Naloxone Sublingual Film 12 mg/3 mg by Ingenus Pharmaceuticals, LLC. The label indicates it contains 30 pouches, each with one sublingual film. The label includes warnings about accidental ingestion by children and storage instructions.*

FDA Label Image

Ctn8mg.jpg (Ctn8mg)

Packaging label for Buprenorphine and Naloxone Sublingual Film, 8 mg/2 mg strength. The label states the product is for sublingual use, contains 30 pouches each with 1 film, and is Rx only. It is manufactured by Ingenus Pharmaceuticals, LLC. The label includes dosage instructions and safety warnings regarding accidental ingestion by children.*

FDA Label Image

Figure3.jpg (Figue3)

Illustration showing a mouth opened wide with a highlighted area on the lower lip and underside, representing the buccal and sublingual regions for film placement.*

FDA Label Image

Figure1.jpg (Figure1)

An instructional illustration showing hands opening a foil pouch containing a buccal or sublingual film. The images demonstrate peeling the pouch apart to access the film dosage form for administration.*

FDA Label Image

Figure2.jpg (Figure2)

An instructional illustration showing hands opening a pouch by tearing along the indicated notch and then pulling the film strip from inside. It demonstrates proper handling of a medication film package for buccal or sublingual administration.*

FDA Label Image

Figure4.jpg (Figure4)

Instructional diagram showing placement of a buccal or sublingual film inside the mouth. One panel depicts a person using fingers to place the film inside the cheek, and the other panel shows the film positioned on the inside of the cheek or under the tongue.*

FDA Label Image

Structurebuprenorpine.jpg (Structurebuprenorpine)

Chemical structure of buprenorphine hydrochloride, showing its molecular framework including hydroxyl, methoxy, and cyclopropyl groups, with the hydrochloride (HCl) notation indicated.*

FDA Label Image

Structurenaloxone.jpg (Structurenaloxone)

Chemical structure of buprenorphine, an active ingredient in the Buprenorphine and Naloxone film product. The structure includes multiple rings with hydroxyl groups and a hydrochloride dihydrate salt indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.